ABSTRACT
Introduction
Primary hypertension is of unknown etiology; its diverse hemodynamic and pathophysiologic derangements are unlikely to result from a single cause (22, 8, 2) . Heredity is a predisposing factor (11) , but the exact mechanism is unclear. Environmental factors (eg. high salt intake, obesity, stress) seem to act only in genetically susceptible persons (5) . The renin-angiotensin system (RAS) may be the most important of the endocrine systems that affect the control of blood pressure (10, 17, 15) . This system has been implicated in the pathological changes of organ damage through modulation of gene expression, proliferation, fibrosis, and inflammatoy response (19, 9, 18) . Angiotensin I-converting enzyme (ACE) is a component of RAS. ACE is a key enzyme in the generation of angiotensin (AT)-II (a potent vasoconstrictor and aldosteronestimulating peptide) from AT-I (a vasoinactive decapeptide). The ACE gene consists of 26 exons and 25 introns and spans 21 kb on chromosome 17q23 (7, 13) . The polymorphism consists of the presence (I allele) or absence (D allele) of a 287 bp Alu repeat sequence resulting in 3 genotypes (DD and II homozygote, and ID heterozygote) (21) . An I/D (region in intron 16) polymorphism of the ACE gene correlates with circulating ACE plasma activity (21); higher plasma ACE activity is observed in subjects with ACE-D (16) . An increase in plasma ACE activity may increase blood pressure through increased production of angiotensin II. Studies have demonstrated that ACE insertion (I) / deletion (D) polymorphism is not only associated with diabetes (4, 6), coronary heart disease (23), and diabetic nephropathy (24) , but have also demonstrated that ACE I/D polymorphism is associated with hypertension (3, 12) . In primary hypertension no early pathologic changes occur. Ultimately, generalized arteriolar sclerosis develops; it's particularly apparent in the kidney (nephrosclerosis) and is characterized by medial hypertrophy and hyalinization. Nephrosclerosis is the hallmark of primary hypertension, left ventricular hypertrophy and, eventually, dilation develops gradually. This study was designed to investigate whether ACE I/D polymorphism is associated with primary hypertension in Turkish subjects in Trakya region.
Materials and Methods

Materials
All reagents for PCR Amplification and Gel Electrophoresis were purchased from Fermentas Life Sciences (ELİPS), Istanbul, Turkey. All other chemicals were bought from Sigma or Merck, Darmsladt, Germany, and were of the highest purity available. 
Methods
Blood Pressure
Blood pressure was measured in the morning follow 12 hours fasting by using manual sphingomanometre after resting for 5 minutes in seated position. Presence of hypertension was defined as systolic blood pressure (SBP) ≥ 140 mm Hg and/or diastolic blood pressure (DBP) ≥ 90 mm Hg. DNA Extraction DNA was extracted from whole blood containing ethylenediamine-tetraacetic acid (EDTA) as an anticoagulant by a standard salting-out procedure, followed by phenol/chloroform extraction and resuspended in a TE (10 mmol/L Tris / 1 mmol/L EDTA pH 7.6) buffer (1) . DNA purity and quantity were assessed by absorbance values in spectrophotometre and checked by 0.5% agarose gel electrophoresis. 
Determination of genotypes
Detection of ACE Polymorphism by Electrophoresis
The reaction products were electrophorized on 2 % agarose gels and stained with ethidium bromide. Under ultraviolet light two bands, insertion (I; 490bp) and deletion (D; 190 bp) were visible (Figure) . The 335 bp fragmet was identified on 3 % agarose gels and stained with ethidium bromide. The reaction yields no product in the sample of DD genotype.
Statistical Analysis
Chi square tests according to pearson were performed to compare the frequency of ACE genotype between the groups. A P value <0.05 was considered significant.
Results and Discussion
At baseline the two groups were similar with regard to sex, age, and body mass index ( Table 1) . Primary hypertension patients had higher systolic and diastolic blood pressures.
Group 1, normal controls; group 2, patients group. Data are expressed as means ± SEM. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure. Table 2 shows the ACE genotype distributions of normal controls and patients with primary hypertension.
Several studies have shown a high prevalence of the DD genotype among patients with primary hypertension (6) . On the other hand, researches have shown no differences in the allele frequencies and genotype distributions of ACE gene polymorphisms between the control and hypertension group (14) . In our study, the overall frequencies of the genotypes II, ID, and DD were 31.9, 36.2, and 31.9, respectively in men, and 17.8, 51.1, and 31.1 respectively in women. The individual allele frequencies for I and D were 50.0% for each in men, while in women it was 43.3, 56.7 respectively, and 47.4%, 52.6% respectively in the entire sample. The observed genotype frequencies are in agreement with frequencies predicted by Hardy-Weinberg equilibrium.
The frequencies of the genotypes II, DI, and DD were 29.2, 39.6 and 31.2 respectively in male patient group, whereas the frequencies of the genotypes II, DI, and DD were 37.5, 29.2 and 33.3 respectively in male control group. Statistical analyses have shown no statistically significant difference between the frequencies of the genotype of the two groups.
The frequencies of the genotypes II, DI, and DD were 16.1, 48.4 and 35.5 respectively in female patient group, whereas the frequencies of the genotypes II, DI, and DD were 21.4, 57.2 and 21.4 respectively in female control group. Analyses of this data have shown that the frequencies of the DD genotype in female patient group were statistically significantly higher than that in female control group.
This study have verified a relationship between the ACE DD genotype and the development of primary hypertension in female population of Trakya, but this relationship was not reflected to be true for the male population.
